Depleting FAP+ tumor stromal cells significantly increased the overall Trp-1-specific CD8+T cell response in blood (p=0.038, area under the curve); differences were more pronounced at later time points, i.e. on days 35 and 50 after vaccination (Figure 7D). The gene discussed is CD8A; the disease is neoplasm.